PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
2.140
-0.555 (-20.59%)
At close: Mar 28, 2024, 4:00 PM
2.268
+0.128 (5.98%)
After-hours: Mar 28, 2024, 6:14 PM EDT

PAVmed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
2.450.380.5000000
Revenue Growth (YoY)
550.40%-24.60%-------
Cost of Revenue
6.423.610.59000000
Gross Profit
-3.97-3.24-0.09000000
Selling, General & Admin
48.5360.7334.3212.397.676.315.413.931.29
Research & Development
14.2825.3419.8510.966.634.252.621.720.49
Other Operating Expenses
2.021.780.15000000
Operating Expenses
64.8387.8554.3123.3514.310.568.035.651.78
Operating Income
-68.8-91.09-54.39-23.35-14.3-10.56-8.03-5.65-1.78
Interest Expense / Income
0.591.2800.050.032.390.7200
Other Expense / Income
-5.21-3.39-4.0510.872.135.010.76--
Pretax Income
-64.18-88.98-50.35-34.28-16.46-17.97-9.52-5.65-1.78
Net Income
-64.18-88.98-50.35-34.28-16.46-17.97-9.52-5.65-1.78
Preferred Dividends
2.10.280.280.290.270.780.8800
Net Income Common
-66.27-89.26-50.63-34.56-16.73-18.75-10.4-5.65-1.78
Shares Outstanding (Basic)
765321111
Shares Outstanding (Diluted)
765321111
Shares Change
21.78%14.91%63.42%57.07%35.56%65.06%4.04%15.01%-
EPS (Basic)
-9.16-15.03-9.75-10.80-8.10-12.15-10.65-6.60-2.40
EPS (Diluted)
-9.16-15.03-9.75-10.80-8.10-12.15-10.65-6.60-2.40
Free Cash Flow
-51.28-72.53-42.06-21.97-13.38-8.81-6.61-4.48-1.25
Free Cash Flow Per Share
-7.09-12.21-8.14-6.95-6.65-5.93-7.35-5.18-1.66
Gross Margin
-161.83%-858.62%-17.00%------
Operating Margin
-2805.67%-24161.01%-10878.60%------
Profit Margin
-2702.69%-23677.45%-10126.00%------
Free Cash Flow Margin
-2091.27%-19237.40%-8412.00%------
EBITDA
-60.35-85.15-50.12-34.2-16.41-15.57-8.79-5.65-1.78
EBITDA Margin
-2461.09%-22585.68%-10024.20%------
Depreciation & Amortization
3.242.550.230.020.010.010.0100
EBIT
-63.59-87.7-50.35-34.22-16.42-15.58-8.79-5.65-1.78
EBIT Margin
-2593.23%-23263.13%-10069.40%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).